Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratories.

International journal of oncology - 1 Jul 2016

Mendez Pedro, Dang Jennifer, Kim James Wansoo, Lee Sharon, Yoon Jun-Hee, Kim Thomas, Sailey Charles J, Jablons David M, Kim Il-Jin

Abstract excerpt

Next-generation sequencing (NGS) has led to breakthroughs for genetic and genomic analyses and personalized medicine approaches for many diseases. More and more clinical laboratories are using NGS as a genetic screening tool for providing mutation information that is used to select the best treatment regimens for cancer patients. However, several obstacles prevent the routine implementation of NGS technology into...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Testing
Share to Genomics

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Neoplasms

Share to Paraffin Embedding

Share to Pathology, Molecular

Share to Tissue Fixation

Source

Identifiers

PMID: 27121194
DOI: 10.3892/ijo.2016.3497

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratories.PMID 27121194Read ↗

Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.Semantic proximity Read ↗

Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.Semantic proximity Read ↗

[Standardization of next-generation sequencing for detecting mutations associated with targeted therapy and immunotherapy based on dynamic pattern of expandable detection range].Semantic proximity Read ↗

A Pilot Proficiency Testing Study for Assessing Cancer Gene Panel using Patient Samples and Next-generation Sequencing in JapanSemantic proximity Read ↗

Impact and Reproducibility of In-House Targeted Next-Generation Sequencing Biomarker Testing in Non–Small-Cell Lung CancerSemantic proximity Read ↗

Review of Clinical Next-Generation Sequencing.Semantic proximity Read ↗

Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal Cancer.Semantic proximity Read ↗

Development and clinical applications of an enclosed automated targeted NGS library preparation system.Semantic proximity Read ↗

Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysis.Semantic proximity Read ↗

Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing.Semantic proximity Read ↗

The reliable assurance of detecting somatic mutations in cancer-related genes by next-generation sequencing: the results of external quality assessment in China.Semantic proximity Read ↗

Precision cancer genome testing needs proficiency testing involving all stakeholders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.